Ptx to 10 bag by this time next year, page-41

It's hard to disagree with this new thread @BigDaniel. PTX has the potential to be manly multiples of its current share price in this timeframe, the market cap is tiny and plenty of constant news flow along the way. Pipeline will only grow.

PTX - 100 A Registralional study will fast track it's efficacy results substantially as explained by many before cutting out a need for Phase III. Won't be too long until confirmation of this.. I feel the only reason this was not announced with PTX-100 safety results is the time it takes to file.

PTX - 200 data due Q4. Just as much potential as PTX-100 IMO.

Stealth mode cell therapy with Carina Biotech / Uni of Adelaide yet to be unveiled. This has been under wraps since November 2019 plenty of work has gone into this and more work going on behind the scenes in Carina and PTX than what can be communicated. https://small-caps.com.au/prescient-therapeutics-carina-biotech-develop-car-t-cell-solid-tumour-therapies/ (added a dash in the small caps url). I doubt we will have to wait long.

The other Stealth mode cell therapy through Peter Mac yet to be unveiled - Very impressive world-recognized cancer institution and precinct who clearly work well with PTX.

Omnicar - And then the kicker. More info on the clinical designs of the omnicar programs. I can't wait to see what sort of new therapies and collaborations we see Omnicar licensing with between now and then. Not just in Car-T. All the new next-generation therapies like Macrophages, NK Cells, combinations with oncolytic viruses, anyone who are looking for a modular controllable approach. Even an AIDS Car-T.

Maybe we will see a logo like this on immuno-ocology intravenous infusion bags all over the world in the not too distant future...

Or will there be T/O before then?